Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncostatin M | 3 | 2022 | 3 | 1.010 |
Why?
|
| Lipolysis | 1 | 2022 | 13 | 0.730 |
Why?
|
| Insulin | 1 | 2022 | 146 | 0.680 |
Why?
|
| Adipocytes | 3 | 2022 | 31 | 0.450 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2011 | 3 | 0.360 |
Why?
|
| Probiotics | 1 | 2011 | 10 | 0.350 |
Why?
|
| Adipose Tissue | 2 | 2018 | 69 | 0.260 |
Why?
|
| Mice | 4 | 2022 | 746 | 0.220 |
Why?
|
| 3T3-L1 Cells | 2 | 2022 | 6 | 0.220 |
Why?
|
| Choriocarcinoma | 1 | 2003 | 1 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2003 | 29 | 0.190 |
Why?
|
| Animals | 4 | 2022 | 1875 | 0.190 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2022 | 11 | 0.190 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 3 | 0.180 |
Why?
|
| Coercion | 1 | 2019 | 3 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2019 | 60 | 0.140 |
Why?
|
| Crack Cocaine | 1 | 2016 | 5 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 17 | 0.130 |
Why?
|
| Panniculitis | 1 | 2016 | 1 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2016 | 35 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 72 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2016 | 74 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 153 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2016 | 246 | 0.110 |
Why?
|
| Obesity | 1 | 2016 | 226 | 0.100 |
Why?
|
| Humans | 5 | 2019 | 6794 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 5 | 0.090 |
Why?
|
| HIV Infections | 1 | 2016 | 432 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2011 | 89 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 82 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2011 | 331 | 0.080 |
Why?
|
| Adult | 3 | 2019 | 2113 | 0.080 |
Why?
|
| Female | 3 | 2019 | 4060 | 0.060 |
Why?
|
| Young Adult | 2 | 2019 | 567 | 0.060 |
Why?
|
| Male | 3 | 2019 | 3671 | 0.060 |
Why?
|
| Uterine Hemorrhage | 1 | 2003 | 2 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 45 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 21 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2003 | 38 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 79 | 0.050 |
Why?
|
| Aged | 2 | 2019 | 1539 | 0.050 |
Why?
|
| Middle Aged | 2 | 2019 | 2108 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2002 | 16 | 0.050 |
Why?
|
| Immune System | 1 | 2002 | 14 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2002 | 12 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2002 | 23 | 0.040 |
Why?
|
| Pregnancy | 1 | 2003 | 599 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2019 | 1 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 14 | 0.040 |
Why?
|
| Communication | 1 | 2019 | 31 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 22 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 77 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 82 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2018 | 150 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 497 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 7 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 44 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2016 | 1 | 0.030 |
Why?
|
| Oncostatin M Receptor beta Subunit | 1 | 2016 | 1 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2016 | 4 | 0.030 |
Why?
|
| Condoms | 1 | 2016 | 41 | 0.030 |
Why?
|
| CD8 Antigens | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 10 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 9 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2016 | 77 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2016 | 100 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 259 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 120 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 280 | 0.030 |
Why?
|
| Adolescent | 1 | 2016 | 869 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2002 | 1 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2002 | 5 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 18 | 0.010 |
Why?
|
| Monocytes | 1 | 2002 | 14 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 25 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 20 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cytokines | 1 | 2002 | 80 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 231 | 0.010 |
Why?
|